Insufficient scRNA-seq data for expression of HYAL4 at single-cell level.
Insufficient scRNA-seq data for expression of HYAL4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
muscle | 95% | 234.83 | 763 / 803 | 0% | 0 | 0 / 0 |
skin | 59% | 35.84 | 1061 / 1809 | 3% | 0.08 | 14 / 472 |
kidney | 37% | 12.42 | 33 / 89 | 5% | 0.32 | 43 / 901 |
thymus | 17% | 7.94 | 111 / 653 | 1% | 0.05 | 7 / 605 |
heart | 18% | 4.26 | 154 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 17% | 14.07 | 157 / 929 | 0% | 0 | 0 / 0 |
breast | 13% | 3.75 | 58 / 459 | 2% | 0.05 | 21 / 1118 |
adrenal gland | 13% | 5.36 | 34 / 258 | 0% | 0.03 | 1 / 230 |
spleen | 12% | 5.41 | 29 / 241 | 0% | 0 | 0 / 0 |
lung | 8% | 2.01 | 46 / 578 | 4% | 0.09 | 45 / 1155 |
bladder | 5% | 16.62 | 1 / 21 | 7% | 0.23 | 35 / 504 |
esophagus | 4% | 1.57 | 63 / 1445 | 7% | 0.25 | 13 / 183 |
stomach | 8% | 2.29 | 29 / 359 | 3% | 0.07 | 9 / 286 |
ovary | 10% | 2.29 | 18 / 180 | 1% | 0.02 | 4 / 430 |
pancreas | 5% | 1.59 | 15 / 328 | 5% | 0.80 | 9 / 178 |
uterus | 4% | 0.83 | 6 / 170 | 5% | 0.14 | 21 / 459 |
intestine | 4% | 1.05 | 38 / 966 | 3% | 0.07 | 17 / 527 |
prostate | 6% | 2.46 | 15 / 245 | 1% | 0.03 | 5 / 502 |
adipose | 6% | 1.91 | 74 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.10 | 2 / 45 |
liver | 3% | 0.63 | 6 / 226 | 2% | 0.04 | 7 / 406 |
blood vessel | 3% | 0.77 | 42 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 3% | 0.10 | 2 / 80 |
brain | 0% | 0.04 | 5 / 2642 | 0% | 0.00 | 2 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0005975 | Biological process | carbohydrate metabolic process |
GO_0030207 | Biological process | chondroitin sulfate catabolic process |
GO_0030214 | Biological process | hyaluronan catabolic process |
GO_0006027 | Biological process | glycosaminoglycan catabolic process |
GO_0009986 | Cellular component | cell surface |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0016020 | Cellular component | membrane |
GO_0004415 | Molecular function | hyalurononglucosaminidase activity |
Gene name | HYAL4 |
Protein name | Hyaluronidase-4 (Hyal-4) (EC 3.2.1.35) (Chondroitin sulfate endo-beta-N-acetylgalactosaminidase) (Chondroitin sulfate hydrolase) (CSHY) (Hyaluronoglucosaminidase-4) Hyaluronidase (EC 3.2.1.35) Hyaluronidase 4 |
Synonyms | |
Description | FUNCTION: Endo-hyaluronidase that degrades hyaluronan to smaller oligosaccharide fragments. Has also chondroitin sulfate hydrolase activity, The best substrate being the galactosaminidic linkage in the sequence of a trisulfated tetrasaccharide. . |
Accessions | F8WDH9 C9J6F9 ENST00000488323.5 ENST00000223026.9 Q2M3T9 ENST00000476325.5 C9JU18 ENST00000483878.1 ENST00000489978.5 |